Status:
UNKNOWN
Safe Return to Regular Clinical Operation After COVID-19 Pandemic
Lead Sponsor:
King Fahad Specialist Hospital Dammam
Conditions:
COVID 19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
. Coronavirus (SARS-CoV2) appeared first in China late 2019 and caused an acute respiratory disease referred to as Coronavirus disease 2019 (COVID-19). SARS-CoV2 is considered by the World Health Orga...
Detailed Description
Coronavirus (SARS-CoV2) appeared first in China late 2019 and caused an acute respiratory disease referred as Coronavirus disease 2019 (covid-19). SARS-CoV2 is considered by the World Health Organizat...
Eligibility Criteria
Inclusion
- all Health care provider at KFSH D
Exclusion
- NA
Key Trial Info
Start Date :
May 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04377802
Start Date
May 17 2020
End Date
December 30 2020
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
king Fahad specialist hospital
Dammam, Eastern Province, Saudi Arabia, 31444